Rite Aid (NYSE:RAD) will be releasing its earnings data after the market closes on Wednesday, January 3rd. Analysts expect Rite Aid to post earnings of ($0.02) per share for the quarter.

Rite Aid (NYSE:RAD) last announced its quarterly earnings results on Thursday, September 28th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01). The company had revenue of $7.68 billion for the quarter, compared to analysts’ expectations of $7.83 billion. Rite Aid had a net margin of 0.28% and a negative return on equity of 7.51%. The business’s quarterly revenue was down 4.4% compared to the same quarter last year. During the same period last year, the firm posted $0.03 earnings per share. On average, analysts expect Rite Aid to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Rite Aid (NYSE:RAD) opened at $2.02 on Wednesday. The firm has a market cap of $2,150.00, a price-to-earnings ratio of 25.25 and a beta of 1.80. Rite Aid has a 52-week low of $1.38 and a 52-week high of $8.77. The company has a current ratio of 1.74, a quick ratio of 0.77 and a debt-to-equity ratio of 9.71.

In related news, Director Myrtle S. Potter sold 28,189 shares of the firm’s stock in a transaction on Tuesday, October 3rd. The shares were sold at an average price of $2.09, for a total transaction of $58,915.01. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 2.29% of the company’s stock.

A number of brokerages have recently weighed in on RAD. Zacks Investment Research raised shares of Rite Aid from a “sell” rating to a “hold” rating in a research report on Friday, November 17th. Royal Bank of Canada set a $2.00 price objective on shares of Rite Aid and gave the stock a “hold” rating in a report on Wednesday, October 25th. Loop Capital restated a “hold” rating and set a $2.00 price objective (down from $2.50) on shares of Rite Aid in a report on Friday, September 29th. Guggenheim restated a “neutral” rating and set a $2.00 price objective on shares of Rite Aid in a report on Monday, October 2nd. Finally, Mizuho set a $2.00 price objective on shares of Rite Aid and gave the stock a “hold” rating in a report on Saturday, October 7th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating, two have issued a buy rating and one has issued a strong buy rating to the stock. Rite Aid presently has a consensus rating of “Hold” and a consensus price target of $3.25.

COPYRIGHT VIOLATION NOTICE: “Rite Aid (RAD) Set to Announce Earnings on Wednesday” was reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this story on another website, it was illegally copied and republished in violation of US & international copyright & trademark laws. The legal version of this story can be accessed at https://theolympiareport.com/2017/12/27/rite-aid-rad-set-to-announce-earnings-on-wednesday.html.

About Rite Aid

Rite Aid Corporation is a retail drugstore chain. The Company’s segments include Retail Pharmacy and Pharmacy Services. The Company operates under The Rite Aid name. It operates approximately 4,560 stores in over 30 states across the country and in the District of Columbia. The Company’s Retail Pharmacy segment consists of Rite Aid stores, RediClinic and Health Dialog.

Earnings History for Rite Aid (NYSE:RAD)

Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.